Evercore ISI likes the expansion of pemvidutide into alcohol liver disease and alcohol use disorder as it adds another leg to the pemvidutide ...
Morgan Stanley lowered the firm’s price target on Evercore (EVR) to $306 from $400 and keeps an Overweight rating on the shares. The robust ...
Albertsons Companies (NYSE:ACI – Get Free Report) had its target price lifted by research analysts at Evercore ISI from $21.00 to $22.00 in a report issued on Tuesday,Benzinga reports. The brokerage ...
Kyle Walters, a private equity analyst at PitchBook, pointed out that sponsoring all these sports can be quite expensive, and ...
Discover why Jefferies Financial Group is a strong buy at ~$55, with improving efficiency, diverse revenue streams, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results